Clinical Trials Directory

Trials / Completed

CompletedNCT06853353

Nurse-led Consultations in Heart Failure Within the 'FIL-EAS' Evaluation and Support Care Pathway for Heart Failure Patients

Status
Completed
Phase
Study type
Observational
Enrollment
137 (actual)
Sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The management of chronic heart failure, following current guidelines, requires the implementation and adjustment of therapies to limit mortality and morbidity associated with disease progression. However, this period of treatment titration remains challenging due to the need for multiple, closely spaced consultations. The difficulty in maintaining this consultation frequency, coupled with the current decline in medical demographics, largely explains the lack of treatment titration or even initiation and the existing therapeutic inertia. Concurrently, medical telemonitoring is emerging as an essential tool in heart failure management, offering significant benefits for both patients and healthcare professionals. In this context, new forms of nursing practices have emerged, such as advanced practice nursing, aimed at improving the care of patients with chronic diseases. However, only limited data are currently available regarding the functioning and impact of these consultations in France. The "Evaluation and Support Pathway for Heart Failure Patients (FIL-EAS ic)" has systematically integrated this new model of consultations provided by heart failure nurse specialists. Given their significant and growing role within the pathway, it appears necessary to thoroughly evaluate these consultations to propose improvements and maximize their effectiveness.

Conditions

Interventions

TypeNameDescription
OTHERHeart Failure Specialist Nurses consultationsHeart Failure Specialist Nurses consultations

Timeline

Start date
2025-02-25
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2025-02-28
Last updated
2026-04-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06853353. Inclusion in this directory is not an endorsement.